Your session is about to expire
← Back to Search
Active Delta-9-THC for Healthy Subjects (THC-Preg Trial)
THC-Preg Trial Summary
This trial will study the effects of a hormone on the short-term mental effects of marijuana.
THC-Preg Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTHC-Preg Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.THC-Preg Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
What criteria must a potential participant meet in order to be approved for this clinical trial?
"This medical study is actively seeking 38 participants, aged 18 to 55 with a history of cannabis exposure. As healthy subjects (HS), they must meet the criteria specified by the clinical trial protocol."
What is the recruitment size of this clinical trial?
"This study is no longer enrolling patients. It was initially posted on February 1st 2015 and the last update was made July 27th 2022. Alternatives to this trial can be found in the form of 841 studies seeking out healthy volunteers, as well as 43 trials that actively recruiting for Active Delta-9-THC research."
To what degree does Active Delta-9-THC pose a threat to individuals?
"As this is a Phase 1 assessment, there is restricted data confirming the safety and efficacy of delta-9-THC, hence our team at Power estimated its security level to be 1 on a scale from one to three."
Is this experiment currently recruiting participants?
"This trial is now closed to new participants, as its last update was on July 27th 2022. Alternately, 841 clinical trials recruiting healthy volunteers and 43 experiments studying Active Delta-9-THC are currently open for enrolment."
Does the research team require participants to be of legal age?
"According to the study's eligibility requirements, participants must be aged 18 at a minimum and 55 at a maximum."
Are there any prior investigations associated with Active Delta-9-THC?
"Presently, there are 43 clinical trials actively researching the effects of Active Delta-9-THC with 6 in their third phase. Although Belmont, Massachusetts harbors several of these trials, they can also be found across 96 other sites."
For what maladies has Active Delta-9-THC demonstrated efficacy?
"Active Delta-9-THC is a viable therapeutic option for those dealing with weight loss, inadequate response to conventional therapy, and pharmacotherapy."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger